Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

BioMarin to Acquire Alesta Therapeutics for Up to $490 Million

BioMarin Pharmaceutical Inc. filed a current report on Form 8-K on August 18, 2026, disclosing that it entered into a Share Purchase Agreement on August 17, 2026, to acquire Alesta Therapeutics B.V., a private Dutch rare disease company, for an upfront payment of $275 …

Vinay Lochav | 18 August 2026

GE HealthCare Names William Grogan as New CFO

GE HealthCare Technologies Inc. filed a current report on August 18, 2026, disclosing that its Board of Directors appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.

Aakashdeep | 18 August 2026

Privia Health Elects Opella Ernest to Board of Directors

Privia Health Group, Inc. filed a Form 8-K on August 18, 2026, disclosing that its Board of Directors elected Opella Ernest, M.D. as a Class III director, effective September 1, 2026.

Aakashdeep | 18 August 2026

Virgin Galactic Derivative Lawsuit Settlement Gets Final Approval

Virgin Galactic Holdings, Inc. filed a current report on August 18, 2026, disclosing that a U.S. federal court granted final approval of the settlement of two consolidated derivative lawsuits against the company.

Aditi Sarkar | 18 August 2026

Xylem Names New CFO as Grogan Resigns

Xylem Inc. filed a Form 8-K with the SEC on August 18, 2026, disclosing the resignation of Chief Financial Officer William K. Grogan and the appointment of Andrea van der Berg as his successor, effective September 1, 2026.

Vinay Lochav | 18 August 2026

Amylyx Reports Positive Phase 3 Data for Avexitide in PBH

Amylyx Pharmaceuticals, Inc. filed a Form 8-K on August 18, 2026, disclosing positive topline results from its Phase 3 LUCIDITY clinical trial evaluating avexitide in participants with post-bariatric hypoglycemia following Roux-en-Y gastric bypass surgery.

Aditi Sarkar | 18 August 2026

Amylyx Pharmaceuticals Shares LUCIDITY Phase 3 Trial Results

Amylyx Pharmaceuticals, Inc. filed a Form 8-K on August 18, 2026, disclosing that it hosted an investor and analyst conference call on that date to discuss positive topline results from the LUCIDITY Phase 3 clinical trial evaluating avexitide in participants with post-bariatric hypoglycemia following …

Vinay Lochav | 18 August 2026

Universal Technical Institute Enters $200M Revolving Credit Facility

Universal Technical Institute, Inc. filed a current report on August 18, 2026, disclosing that on August 12, 2026, it entered into a new senior secured revolving credit facility of up to $200 million with Fifth Third Bank as administrative agent and a group of …

Aakashdeep | 18 August 2026

Infleqtion Amends Q2 2026 Earnings Release After Revenue Adjustments

Infleqtion, Inc. filed a Form 8-K/A amendment on August 17, 2026, correcting its preliminary financial results for the quarter ended June 30, 2026, after identifying adjustments related to revenue recognition and cost of revenue accounting.

Shwetambri Chauhan | 18 August 2026

Rexford Industrial Realty to Sell 22 Properties for $1.2 Billion

Rexford Industrial Realty, Inc. filed a current report on August 18, 2026, disclosing that its operating partnership entered into an agreement on August 13, 2026, to sell a portfolio of 22 industrial properties to an affiliate of EQT Real Estate for approximately $1.2 billion …

Vinay Lochav | 18 August 2026
Support

Hi! How can we help you today?

Loading…